What is the optimum antibiotic prophylaxis in patients undergoing implantation of a left ventricular assist device?

Interactive Cardiovascular and Thoracic Surgery

Volumn 14, Issue 2, 2012, Pages 209-214

  Acharya, Metesh Nalin ^a   Som, Robin ^a   Tsui, Steven ^b  

^a WATFORD GENERAL HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Antibiotic; Infection; Left ventricular assist device; Prophylaxis

Indexed keywords

AMPHOTERICIN B; AZTREONAM; BETA LACTAM; CEFAMANDOLE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCONAZOLE; LEVOFLOXACIN; NORFLOXACIN; POLYMYXIN B; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TOBRAMYCIN; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DEVICE INFECTION; EVIDENCE BASED MEDICINE; HUMAN; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS; RETROSPECTIVE STUDY; STAPHYLOCOCCUS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BENCHMARKING; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856954884     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivr054     Document Type: Article

References (15)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact Cardio Vasc Thorac Surg 2003;2:405-9. (Pubitemid 38112771)
2. Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg 2010;90:1270-7.
3. Simon D, Fischer S, Grossman A, Downer C, Hota B, Heroux A et al. Left ventricular assist-device related infection: treatment and outcome. Clin Infect Dis 2005;40:1108-15. (Pubitemid 40490234)
4. Holman WL, Park SJ, Long JW, Weinberg A, Gupta L, Tierney AR et al. REMATCH Investigators. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 2004;23:1359-65. (Pubitemid 40018157)
5. Herrmann M, Weyand M, Greshake B, von Eiff C, Proctor RA, Scheld HH et al. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation 1997;95:814-7. (Pubitemid 27091519)
6. Malani PN, Dyke DB, Pagani FD, Chenoweth CE. Nosocomial infections in left ventricular assist device recipients. Clin Infect Dis 2002;34:1295-300. (Pubitemid 34507937)
7. Zierer A, Melby SJ, Voeller RK, Guthrie TJ, Ewald GA, Shelton K et al. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg 2007;84:515-20. (Pubitemid 47069197)
8. Sinha P, Chen JM, Flannery M, Scully BE, Oz MC, Edwards NM. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation 2000;102:III194-9.
9. Schaffer JM, Allen JG, Weiss ES, Arnaoutakls GJ, Patel ND, Russell SD et al. Infectious complications after pulsatile-flow and continuous-flow left ventricular implantation. J Heart Lung Transplant 2011;30:164-74.
10. Grossi P, Dalla Gasperina D, Pagani F, Marone P, Viganò M, Minoli L. Infectious complications in patients with the Novacor left ventricular assist system. Transplant Proc 2001;33:1969-71. (Pubitemid 32238141)
11. Fischer SA, Trenholme GM, Costanzo MR, Piccione W. Infectious complications in left ventricular assist device recipients. Clin Infect Dis 1997;24:18-23. (Pubitemid 27023667)
12. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D et al. HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51.
13. Hannan MM, Husain S, Mattner F, Danziger-Isakov L, Drew RJ, Corey GR et al International Society for Heart and Lung Transplantation. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant 2011;30:375-84.
14. Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR; Society of Thoracic Surgeons. The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration. Ann Thorac Surg 2006;81:397-404. (Pubitemid 41815461)
15. Engelman R, Shahian D, Shemin R, Guy TS, Bratzler D, Edwards F et al. Workforce on Evidence-Based Medicine, Society of Thoracic Surgeon, The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice. Ann Thorac Surg 2007;83:1569-76.